Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 13.15B | 13.71B | 15.69B | 16.34B | 16.09B |
Gross Profit | 3.17B | 4.06B | 5.95B | 7.41B | 7.23B |
EBITDA | 3.00B | 3.86B | 5.91B | 7.73B | 7.58B |
Net Income | 1.79B | 5.12B | 3.26B | 3.11B | 4.13B |
Balance Sheet | |||||
Total Assets | 114.90B | 118.55B | 116.33B | 112.93B | 112.59B |
Cash, Cash Equivalents and Short-Term Investments | 29.55B | 39.33B | 31.65B | 33.53B | 32.20B |
Total Debt | 1.12B | 1.53B | 2.01B | 2.35B | 2.86B |
Total Liabilities | 14.07B | 15.73B | 15.93B | 17.78B | 18.82B |
Stockholders Equity | 100.23B | 102.23B | 99.84B | 94.56B | 93.11B |
Cash Flow | |||||
Free Cash Flow | 0.00 | 1.56B | -746.00M | 2.88B | 1.96B |
Operating Cash Flow | 0.00 | 2.81B | 921.00M | 5.14B | 3.72B |
Investing Cash Flow | 0.00 | 7.23B | -1.51B | -2.29B | -1.46B |
Financing Cash Flow | 0.00 | -2.36B | -1.29B | -1.52B | -2.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $3.76T | 19.53 | 7.99% | 1.40% | 4.42% | 13.51% | |
73 Outperform | $4.32T | 14.05 | 9.89% | 1.92% | 14.07% | 52.59% | |
72 Outperform | $2.82T | 14.69 | 8.98% | 1.17% | -3.73% | -1.31% | |
72 Outperform | $577.07B | 10.53 | 10.28% | 3.84% | -16.67% | 3.49% | |
71 Outperform | ¥231.28B | 14.92 | 10.65% | 3.51% | 19.75% | 24.05% | |
70 Outperform | €177.73B | 16.13 | 8.80% | 3.02% | 11.59% | 86.58% | |
65 Neutral | ¥71.22B | 38.58 | 1.87% | 1.31% | 2.97% | -62.10% |